CENTER FOR BREAKTHROUGH MEDICINES
Live / Registered — Registered (as of 08 Jun 2021)
What this means for you
Registered since 08 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88981530
- Registration number
- 6382057
- Mark type
- Stylized text
- Filed
- 12 Dec 2019
- Published for opposition
- 12 Jan 2021
- Registered
- 08 Jun 2021
- Attorney of record
- Joshua M. Gerben, Esq.
Goods and services
- Class 040 — Treatment of materials: Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting
- Class 042 — Scientific and technological services: Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research
Owner
- CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC, KING OF PRUSSIA, PA, US
- MORNING LIGHT IP, LLC, Radnor, PA, US
- MORNING LIGHT IP, LLC, Radnor, PA, US
- MORNING LIGHT IP, LLC, Radnor, PA, US
Prosecution history
- 19 Oct 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 06 May 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 May 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Apr 2021 — USE AMENDMENT FILED
- 03 May 2021 — DIVISIONAL PROCESSING COMPLETE
- 05 Apr 2021 — DIVISIONAL REQUEST RECEIVED
- 26 Apr 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Apr 2021 — TEAS STATEMENT OF USE RECEIVED
- 05 Apr 2021 — TEAS REQUEST TO DIVIDE RECEIVED
- 09 Mar 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Jan 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Jan 2021 — PUBLISHED FOR OPPOSITION
- 23 Dec 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED